retatrutide phase 2 trial obesity nejm 2023 triple agonist of for Advancements in Clinical Research and

We view it as an all-in-one daily drink mix to support healthy functioning, prepare for daily performance, and improve recovery

A 50 mg dose equals 10 mL which is the entire vial reconstituted at 5 mg/mL

The root cause of gout is hyperuricemia and it is characterized by recurrent attacks of acute inflammatory arthritis

Dizziness Although a bit rare, some people feel dizzy and lightheaded right after treatment due to temporary changes in blood pressure

Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied herein

2026;5(1):DOI:10.1136/ bmjmed-2025-002150